BioLamina’s Post

View organization page for BioLamina, graphic

10,289 followers

Don't miss these poster sessions in a bit! ➡ From 3:45 to 4:45, Dr. Malin Kele (Eriksson), our Director Business Development, will present poster #269: “Gene editing cells using CRISPR-Cas9 on Biolaminin® 521 improves single-cell survival and cloning, enabling consecutive differentiation of human pluripotent stem cells on biorelevant matrices” ➡ Also from 3:45 to 4:45, you might be interested in Charlotte Janssens 's poster presentation #559 "Xeno/feeder-free culture using laminin supports resetting towards naive pluripotency in human embryonic stem cells". Check how her team at the Research Group Reproduction and Genetics, Vrije Universiteit Brussel, aimed to mimic the natural environment by culturing cells on Biolaminin® LN 521, which is one of the first cell adhesion proteins present in the inner cell mass of human blastocysts. ➡ From 4:45 to 5:45, don't miss Dr. Therese Kallur, our CSO and VP Business Development! She will present poster #254 “Organ-specific expression data steer choice of laminin proteins for in vitro studies, for biologically relevant drug discovery and development platforms” See you there, bis bald!

To view or add a comment, sign in

Explore topics